Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1987-8-20
|
pubmed:abstractText |
Triethyllead chloride and 2,5-hexanedione are known neurotoxicants that apparently work through separate mechanisms. The effect of combined treatment of triethyllead chloride and 2,5-hexanedione for 6 weeks on Fischer 344 rats was investigated. Ten rats were given 0.7 mg/kg triethyllead chloride in a volume of 2 ml/kg by gavage while another group was given 0.5% 2,5-hexanedione in drinking water and vehicle by gavage (2 ml/kg). A third group was given a combination of the two treatments. A fourth group served as controls and was given vehicle by gavage. 2,5-Hexanedione produced a reversible loss of body weight, decreased grip strength, and decreased horizontal motor activity. Triethyllead chloride alone increased hot-plate latencies. Triethyllead chloride and 2,5-hexanedione treated animals recovered 4 weeks after cessation of treatment. Neither treatment alone produced fatalities. In combination (2,5-hexanedione + triethyllead chloride) decreases in body weight appeared additive and there was a 40% mortality by 6 weeks of dosing. Rats given the combined treatment had significant loss of both grip strength and increased hot-plate latencies. Neurobehavioral deficits and neuropathological changes were greater in the combined treatment with 2,5-HD and TEL than when either chemical was used alone; there was little indication of a synergistic interaction between these two types of neurotoxicants.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2,5-hexanedione,
http://linkedlifedata.com/resource/pubmed/chemical/Hexanones,
http://linkedlifedata.com/resource/pubmed/chemical/Ketones,
http://linkedlifedata.com/resource/pubmed/chemical/NADH Dehydrogenase,
http://linkedlifedata.com/resource/pubmed/chemical/Organometallic Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/triethyllead
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0098-4108
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
483-92
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3599091-Administration, Oral,
pubmed-meshheading:3599091-Animals,
pubmed-meshheading:3599091-Body Weight,
pubmed-meshheading:3599091-Drug Synergism,
pubmed-meshheading:3599091-Hexanones,
pubmed-meshheading:3599091-Ketones,
pubmed-meshheading:3599091-Liver,
pubmed-meshheading:3599091-Male,
pubmed-meshheading:3599091-Motor Activity,
pubmed-meshheading:3599091-NADH Dehydrogenase,
pubmed-meshheading:3599091-Organometallic Compounds,
pubmed-meshheading:3599091-Rats,
pubmed-meshheading:3599091-Rats, Inbred F344,
pubmed-meshheading:3599091-Reaction Time,
pubmed-meshheading:3599091-Sciatic Nerve
|
pubmed:year |
1987
|
pubmed:articleTitle |
Neurotoxic effects of combined treatment of 2,5-hexanedione and triethyllead chloride.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|